Shannon Grant

753 total citations
18 papers, 299 citations indexed

About

Shannon Grant is a scholar working on Rheumatology, Infectious Diseases and Virology. According to data from OpenAlex, Shannon Grant has authored 18 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 4 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Shannon Grant's work include Rheumatoid Arthritis Research and Therapies (5 papers), HIV, Drug Use, Sexual Risk (4 papers) and HIV Research and Treatment (3 papers). Shannon Grant is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), HIV, Drug Use, Sexual Risk (4 papers) and HIV Research and Treatment (3 papers). Shannon Grant collaborates with scholars based in United States, Canada and South Africa. Shannon Grant's co-authors include Katherine C. Saunders, Albert L. Waldo, Sanjeev Saksena, April Slee, Yves Rosenberg, Setareh A. Williams, D. George Wyse, Nick Freemantle, Vibeke Strand and Paul Miller and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Shannon Grant

18 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shannon Grant United States 10 99 65 43 40 39 18 299
Nicholas Adlard Switzerland 13 35 0.4× 79 1.2× 47 1.1× 36 0.9× 58 1.5× 46 524
Ellen Maxwell Australia 11 34 0.3× 21 0.3× 28 0.7× 13 0.3× 27 0.7× 18 290
L Santacroce United States 9 17 0.2× 74 1.1× 36 0.8× 21 0.5× 23 0.6× 37 248
Kate Navaratnam United Kingdom 12 47 0.5× 19 0.3× 32 0.7× 41 1.0× 24 0.6× 26 612
Zijun Liao China 11 13 0.1× 38 0.6× 29 0.7× 25 0.6× 18 0.5× 32 319
Piotr Sieroszewski Poland 11 24 0.2× 17 0.3× 38 0.9× 24 0.6× 24 0.6× 81 500
Klaus Strömer Germany 13 18 0.2× 63 1.0× 233 5.4× 19 0.5× 19 0.5× 35 473
Ashley Kim United States 7 14 0.1× 14 0.2× 19 0.4× 31 0.8× 55 1.4× 21 373
Helen Banks Italy 11 47 0.5× 15 0.2× 66 1.5× 24 0.6× 5 0.1× 36 356
Sumaiya Adam South Africa 13 37 0.4× 18 0.3× 23 0.5× 13 0.3× 13 0.3× 45 621

Countries citing papers authored by Shannon Grant

Since Specialization
Citations

This map shows the geographic impact of Shannon Grant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Grant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Grant more than expected).

Fields of papers citing papers by Shannon Grant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Grant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Grant. The network helps show where Shannon Grant may publish in the future.

Co-authorship network of co-authors of Shannon Grant

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Grant. A scholar is included among the top collaborators of Shannon Grant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Grant. Shannon Grant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Espy, Nicole, Xue Han, Shannon Grant, et al.. (2023). Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants. SHILAP Revista de lepidopterología. 3(6). e0002037–e0002037. 2 indexed citations
2.
Fischinger, Stephanie, Deniz Cizmeci, Davy Deng, et al.. (2021). Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials. PLoS Pathogens. 17(11). e1010016–e1010016. 2 indexed citations
3.
Karuna, Shelly, Shuying Sue Li, Shannon Grant, et al.. (2021). Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study. PLoS Medicine. 18(12). e1003868–e1003868. 10 indexed citations
4.
Strand, Vibeke, Paul Miller, Setareh A. Williams, et al.. (2017). Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry. Rheumatology and Therapy. 4(2). 489–502. 46 indexed citations
5.
Huang, Ying, Carlos A. DiazGranados, Holly Janes, et al.. (2016). Selection of HIV vaccine candidates for concurrent testing in an efficacy trial. Current Opinion in Virology. 17. 57–65. 7 indexed citations
6.
Lama, Javier R., Shelly Karuna, Shannon Grant, et al.. (2016). Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection. PLoS ONE. 11(8). e0160487–e0160487. 3 indexed citations
7.
Koblin, Beryl A., Shannon Grant, Victoria Frye, et al.. (2015). HIV Sexual Risk and Syndemics among Women in Three Urban Areas in the United States: Analysis from HVTN 906. Journal of Urban Health. 92(3). 572–583. 28 indexed citations
8.
Harrold, Leslie R., Jeffrey D. Greenberg, Yanjun Bao, et al.. (2014). THU0180 Time to Biologic Therapy Driven by Rheumatoid Arthritis Disease Activity and Severity. Annals of the Rheumatic Diseases. 73. 243–244. 3 indexed citations
9.
Crabtree, Alexis, et al.. (2013). A qualitative study of the perceived effects of blue lights in washrooms on people who use injection drugs. Harm Reduction Journal. 10(1). 22–22. 9 indexed citations
10.
Grant, Shannon, Ying Qing Chen, & Susanne May. (2013). Performance of goodness-of-fit tests for the Cox proportional hazards model with time-varying covariates. Lifetime Data Analysis. 20(3). 355–368. 20 indexed citations
11.
Teo, Koon, Larry B. Goldstein, Bernard Chaitman, et al.. (2013). Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease. Stroke. 44(10). 2688–2693. 25 indexed citations
12.
13.
Ringold, Sarah, Shannon Grant, Charmaine Girdish, Carol A. Wallace, & Sean D. Sullivan. (2013). Injectable Tumor Necrosis Factor α Inhibitors and Outpatient Antimicrobial Use in Children With Rheumatic Diseases: Analyses of Prescription Claims From a Pharmacy Benefit Manager Database. Arthritis Care & Research. 65(11). 1880–1884. 3 indexed citations
14.
Strand, Vibeke, Setareh A. Williams, Paul S.J. Miller, et al.. (2013). OP0064 Discontinuation of Biologic Therapy in Rheumatoid Arthritis (RA): Analysis from the Consortium of Rheumatology Researchers of North America (CORRONA) Database. Annals of the Rheumatic Diseases. 72. A71–A72. 9 indexed citations
15.
Grant, Shannon. (2013). Barriers to safer injection practices faced by people who use intravenous drugs, in Vancouver and Abbotsford, B.C.. 4(2). 1 indexed citations
16.
Ringold, Sarah, Shannon Grant, Charmaine Girdish, Carol A. Wallace, & Sean D. Sullivan. (2012). Methotrexate and Injectable Tumor Necrosis Factor-α Inhibitor Adherence and Persistence in Children with Rheumatic Diseases. The Journal of Rheumatology. 40(1). 80–86. 13 indexed citations
17.
Saksena, Sanjeev, April Slee, Albert L. Waldo, et al.. (2011). Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). Journal of the American College of Cardiology. 58(19). 1975–1985. 92 indexed citations
18.
Maiti, Smarajit, et al.. (2004). Stress regulation of sulfotransferases in male rat liver. Biochemical and Biophysical Research Communications. 323(1). 235–241. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026